DLK1/PREF1 marks a novel cell population in the human adrenal cortex
Irene Hadjidemetriou(Queen Mary University of London), Leonardo Guasti(Queen Mary University of London), Gerard Ruiz‐Babot(Harvard Stem Cell Institute), Celso E. Gómez-Sánchez(Universidade Federal do Estado do Rio de Janeiro), Katja Kiseljak‐Vassiliades(Johns Hopkins University), James Pittaway(Queen Mary University of London), Katia Mariniello(Queen Mary University of London), Tarek Abdel‐Aziz(University College Hospital), Teng‐Teng Chung(University College Hospital), Margaret E. Wierman(University of Colorado Anschutz Medical Campus), Fausto Palazzo(Hammersmith Hospital), Laila Parvanta(St Bartholomew's Hospital), Demetris Mariannis(Queen Mary University of London), William M Drake(St Bartholomew's Hospital), Alessandra Mancini(Brigham and Women's Hospital), Peter King(Australian Maritime College), Aimee N. Di Marco(Imperial College Healthcare NHS Trust)
Cited by 22
Related Papers
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
|Surgery|2011|266
Activating mutations in CTNNB1 in aldosterone producing adenomas
|Scientific Reports|2016|172